Mason RR, Meex RC, Lee-Young R, Canny BJ, Watt MJ. Phosphorylation of adipose triglyceride lipase Ser 404 is not related to 5=-AMPK activation during moderate-intensity exercise in humans. Am J Physiol Endocrinol Metab 303: E534 -E541, 2012. First published June 19, 2012 doi:10.1152/ajpendo.00082.2012.-Intramyocellular triacylglycerol provides fatty acid substrate for ATP generation in contracting muscle. The protein adipose triglyceride lipase (ATGL) is a key regulator of triacylglycerol lipolysis and whole body energy metabolism at rest and during exercise, and ATGL activity is reported to be enhanced by 5=-AMP-activated protein kinase (AMPK)-mediated phosphorylation at Ser 406 in mice. This is a curious observation, because AMPK activation reduces lipolysis in several cell types. We investigated whether the phosphorylation of ATGL Ser 404 (corresponding to murine Ser 406 ) was increased during exercise in human skeletal muscle and with pharmacological AMPK activation in myotubes in vitro. In human experiments, skeletal muscle and venous blood samples were obtained from recreationally active male subjects before and at 5 and 60 min during exercise. ATGL Ser 404 phosphorylation was not increased from rest during exercise, but ATGL Ser 404 phosphorylation correlated with myosin heavy chain 1 expression, suggesting a possible fiber type dependency. ATGL Ser 404 phosphorylation was not related to increases in AMPK activity, and immunoprecipitation experiments indicated no interaction between AMPK and ATGL. Rather, ATGL Ser 404 phosphorylation was associated with protein kinase A (PKA) signaling. ATGL Ser 406 phosphorylation in C2C12 myotubes was unaffected by 5-aminoimidazole-4-carboxaminde-1-␤-D-ribofuranoside, an AMPK activator, and the PKA activator forskolin. Our results demonstrate that ATGL Ser 404 phosphorylation is not increased in mixed skeletal muscle during moderateintensity exercise and that AMPK does not appear to be an activating kinase for ATGL Ser 404/406 in skeletal muscle.
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5=-adenosine monophosphate-activated protein kinase; skeletal muscle; lipolysis; fatty acid metabolism LIPOLYSIS IS A HIGHLY CONSERVED PROCESS that involves the sequential removal of fatty acids from triacylglycerol to supply substrate for ATP production. Free fatty acids (FFA) derived from adipose tissue provide the majority of fatty acid substrate in humans, while energy derived from muscle triacylglycerol lipolysis constitutes an important fuel source, particularly during prolonged moderate intensity exercise (37, 41) . Lipolysis is controlled by the actions of several lipases. Adipose triglyceride lipase (ATGL) is the predominant triacylglycerol lipase and is critical for efficient triacylglycerol lipolysis in all tissues assessed to date (2, 14, 29, 30, 36) , including skeletal muscle (5, 16) . Whole body deletion of ATGL in mice impairs the FFA supply required to sustain normal substrate metabolism, resulting in increased carbohydrate metabolism and impaired exercise performance (14, 16) . In humans, mutations in both alleles of ATGL leads to neutral lipid storage disease, which is characterized by the systemic accumulation of triacylglycerol in cytoplasmic lipid droplets (12) , while immunodepletion of ATGL in human adipose tissue lysates reduces triacylglycerol lipase activity by ϳ80% (34) .
Studies in adipocytes show that ATGL's enzymatic activity is co-activated by the protein comparative gene identification-58 (CGI-58) and inhibited by the protein G0/G1 switch gene 2 (G0S2) (26, 48) . Recent studies also suggest that phosphorylation may be involved in regulating ATGL activity. ATGL was phosphorylated by unknown endogenous kinases in HepG2 cells (50) ) was detected in a phosphoproteomic analysis of purified lipid droplets from HeLa cells (6) and in several murine tissues (17) . Phosphorylation of ATGL by AMP kinase (AMPK) in C. elegans (28) and cyclin-dependent kinase 1 in yeast reduces lipolysis (24) , while AMPK phosphorylation of ATGL Ser 406 appears to increase lipolysis in mice (1) . The latter finding of activating phosphorylation of ATGL by AMPK is surprising given that previous studies in adipose tissue (4, 7, 8, 10, 35) and skeletal muscle (45, 46) have demonstrated an inhibitory role for AMPK on lipolysis and triacylglycerol hydrolase activity. This anti-lipolytic effect is thought to be mediated by AMPKmediated phosphorylation in hormone-sensitive lipase (HSL) Ser 565 that in turn prevents phosphorylation at activating protein kinase A (PKA) phosphorylation sites Ser 563 and Ser 660 (13, 45) . Notably, there is conflicting evidence in adipocytes suggesting that AMPK is required for maximal lipolysis (21, 49) . This establishes the possibility that the triacylglycerol (ATGL) and diacylglycerol (HSL) lipases, which normally act in unison to completely degrade triacylglycerol, are oppositely regulated by AMPK phosphorylation. The factors regulating ATGL triacylglycerol lipase activity are not well described, particularly in muscle. The aims of the present study were to determine whether ATGL Ser 404 phosphorylation was increased during prolonged moderate intensity exercise, when triacylglycerol lipase activity is increased (42) , and to assess whether ATGL Ser 404 phosphorylation is associated with AMPK signaling during exercise in humans.
METHODS
Subjects and experimental design. Nine male participants (23 Ϯ 1 yr, 77 Ϯ 2 kg) provided informed consent after being informed of the procedures and associated risks, which were approved by the Monash University Human Research Ethics Committee (CF09/3091-2009001685) and were conducted in accordance with the Declaration of Helsinki. Participants performed less than 2 h of exercise per week. Participants visited the laboratory on three occasions. On the first, peak pulmonary oxygen uptake (V O2peak) was determined during an incremental cycling test to volitional exhaustion (Lode, Groningen, The Netherlands). Expired O2 and CO2 and ventilation were collected and analyzed online (AEI Technologies, Pittsburgh, PA). V O2peak averaged 3.8 Ϯ 0.2 l/min. At least 3 days later, participants performed a practice trial, which consisted of 60 min of cycling at a workload corresponding to 60% V O2max (140 Ϯ 8 W). V O2 was obtained to confirm the participants' workload. One week later, participants visited the laboratory at 0600 after an overnight fast. Participants were asked to lie supine on a bed, and a Teflon catheter was inserted into an antecubital vein. A blood sample was drawn, and the line was kept patent by intermittent injection of heparinized saline. The vastus lateralis muscle was prepared for percutaneous needle biopsies by making a small incision through the skin and deep fascia under local anesthesia (1% Lidocaine, no epinephrine). An incision was made for each muscle biopsy, and incisions were separated by ϳ3 cm. After ϳ30 min, a resting muscle sample was obtained and rapidly frozen in liquid nitrogen while the subject lay on the bed. The subject moved to the cycle ergometer and commenced cycling for 60 min at 60% V O2peak. Expired gases were obtained for 3 min at 15-min intervals, and venous blood samples were obtained immediately before muscle sampling at 5 and 60 min while the subject remained on the ergometer. Water was consumed ad libitum during the exercise bout.
Plasma epinephrine. Blood for epinephrine determination was treated with EGTA and spun at 8,000 g for 3 min, and the plasma was stored at Ϫ80°C for later analysis. Epinephrine was determined by commercial ELISA according to the manufacturer's instructions (Adrenalin-ELISA, IBL International, Hamburg, Germany). The detection limit of this kit, in our laboratory, was 0.2 nmol/l.
Immunoblot analysis. A rabbit polyclonal antibody raised against the phosphopeptide based on the amino acid sequence of murine ATGL (400 -414) pS406 LRRAQpSLPSVPLSC was purified as described previously (9) . This site is conserved in humans at Ser 404 . Primary antibodies for anti-ATGL, anti-AMPK Thr 172 , anti-AMPK␣, anti-acetyl-CoA carboxylase-␤ (ACC␤), anti-ACC␤-Ser 221 , and phospho-(Ser/Thr) PKA substrate antibody were purchased from Cell Signaling (Danvers, MA). Anti-HSL was purchased from Abcam (Cambridge, UK), and anti-HSL (hormone-senstive lipase) Ser 563 and anti-HSL 565 were generated and validated as described (45) . Skeletal muscle was homogenized (PRO Scientific, Oxford, CT) in RIPA buffer [65 mM Tris·HCl, 150 mM NaCl, 1% NP40 (vol/vol), 0.5% sodium deoxycholate (vol/vol), 0.1% SDS (vol/vol), 10% glycerol (vol/vol)] with 1 mM DTT, protease (Complete Protease Inhibitor Cocktail); Roche Diagnostics, Castle Hill, NSW, Australia, and phosphatase (PhosSTOP Phosphatase Inhibitor Cocktail, Roche Diagnostics) inhibitors. Homogenates were centrifuged at 16,000 g for 30 min, the supernatant was removed, and the protein concentration of the muscle lysates were determined according to the bicinchoninic acid method (Pierce Kit; Progen Industries, Darra, QLD, Australia). Lysates were solubilized in Laemmli sample buffer and boiled for 5 min, resolved by SDS-PAGE on 8 -12% polyacrylamide gels, transferred to polyvinylidene difluoride membranes, blocked with 2.5% bovine serum albumin (BSA), and incubated with primary antibody at 4°C overnight. Membranes were washed and incubated with horseradish peroxidase-conjugated secondary antibody (GE Healthcare, UK), and the immunoreactive proteins were subsequently detected by enhanced chemiluminescence (Sigma-Aldrich). Immunoreactive bands were quantified by densitometry (Image J 1.42q, National Institutes of Health). After detection of phosphoproteins, membranes were stripped [200 nM glycine, 3 mM SDS, 1% Tween 20 (vol/vol), pH 2.2], washed, and reprobed for total protein content where appropriate. For immunoprecipitation experiments, the anti-ATGL antibody was conjugated to protein A beads, and muscle lysates (750 g protein) were incubated overnight at 4°C. Beads were washed, and the proteins were dissociated from the beads, solubilized with 2ϫ Laemmli buffer, and subjected to SDS-PAGE and immunoblotting with AMPK␣. Membranes were stripped and reprobed for ATGL.
AMPK activity. AMPK␣2 and -␣1 activity was measured from muscle lysates essentially as described (27) . Briefly, AMPK␣2 and -␣1 were sequentially immunoprecipitated from 500 g of lysate using polyclonal antibodies to AMPK␣2 and -␣1. AMPK activities in the immune complexes were measured in the presence of 200 M AMP and calculated as picomoles of phosphate incorporated into the SAMS peptide (100 M) per minute per milligram of total protein subjected to immunoprecipitation.
Immunohistochemistry. Serial 10-m sections were cut at Ϫ20°C onto SuperFrost Ultra Plus glass slides. Slides were fixed in Bouin's solution with 0.1% Triton X-100 (Sigma-Aldrich) for 1 h and then rinsed 3 ϫ 5 min in PBS with 0.5% BSA. Sections were blocked in 1% BSA for 1 h and then incubated overnight with mouse anti-mysoin for slow-twitch fibers (A4.840, DSHB, University of Iowa). Sections were washed 3 ϫ 5 min in PBS-0.5% BSA and then incubated in Alexa fluor goat-anti mouse IgM 488. Sections were washed with PBS-0.5% BSA and incubated for 5 min with DAPI (1:1,000, Invitrogen) to enable visualization of nuclei, followed by 2 ϫ 5 min PBS-0.5% BSA wash and being covered. Images were captured using a Zeiss microscope (Zeiss, Oberkochen, Germany) with a AxioCam MR camera using both DAPI UV (340 -380 nm) and FITC (465-495 nm) excitation filters.
Cell culture. Cos-1 and 3T3-L1 fibroblasts were purchased from ATCC (Manassas, VA). 3T3-L1 fibroblasts were differentiated into adipocytes as described (22) . To test the specificity of the ATGL pSer 406 antibody, we performed site-directed mutagenesis to convert the Ser 406 to alanine (ATGL S406A), rendering this site phosphorylation defective. ATGL and ATGL S406A were expressed in Cos-1 cells using Lipofectamine 2000 according to the manufacturers protocols. ATGL cDNA was PCR amplified using Ampli-Taq Gold DNA polymerase (Applied Biosystems, Scoresby,Victoria, Australia) with the following primers: mouse ATGL forward 5=-GGTACCGTTC-CCGAGGGAGACCAAGTGGA-3= and reverse 5=-CCTCGAGCG-CAAGGCGGGAGGCCAGGT-3=. The PCR products were gel purified, subjected to restriction digestion (KpnI/XhoI-ATGL, BamHI/XhoI-CGI-58), subcloned into the multiple cloning site of the pcDNA/HisMax plasmid vector (Invitrogen), and sequence verified. Mutagenesis of ATGL to ATGL S406A was performed with pfx polymerase (Invitrogen) and the following primers (forward ACGTGCCCAGGCTCTGC-CCTCTGTG, reverse CACAGAGGGCAGAGCCTGGGCACGT).
C 2C12 myoblasts were grown in Dulbecco's Modified Eagle Medium (DMEM, GibcoLife Technologies, Mulgrave, VIC, Australia) (5 mmol/l glucose, 10% fetal bovine serum, 1% penicillin-streptomycin) until confluent and were differentiated into myotubes by changing the medium to DMEM with 2% horse serum. Myotubes were serum starved overnight (0.5% serum), washed with phosphate-buffered saline, and incubated for 30 min in DMEM with no additions, 20 M forskolin (Sigma), or 500 M or 2 mM 5-aminoimidazole-4-carboxaminde-1-␤-D-ribofuranoside (AICAR, TRC, ON, Canada). Cells were lysed in ice-cold buffer (see above), passed through a 300-l insulin syringe, and spun at 16,000 g for 30 min at 4°C. The supernatant was used for immunoblot analysis.
Statistical analysis. Data are expressed as means Ϯ SE. Statistical analysis was performed by one-way analysis of variance (ANOVA) with repeated measures, and specific differences were located using a Bonferroni post hoc test (GraphPad Prism version 5.02). Statistical significance was set a priori at P Յ 0.05.
RESULTS
Whole body respiratory and metabolic responses to exercise. Exercise V O 2 averaged 2.2 Ϯ 0.1 l/min at 15 min and remained constant throughout the exercise bout. V O 2 throughout the trial averaged 59 Ϯ 1% V O 2peak . The respiratory exchange ratio at 15 min averaged 0.87 Ϯ 0.01 and decreased to 0.83 Ϯ 0.01 at 60 min. Accordingly, carbohydrate oxidation decreased and fat oxidation increased with the duration of exercise (Table 1) .
Epinephrine was detected in only one of the resting and three of the 5-min plasma samples and averaged 0.25 Ϯ 0.02 nmol/l. Plasma epinephrine increased to 1.56 Ϯ 0.42 nmol/l at 60 min of exercise (Table 1) .
Validation of the ATGL Ser 404 polyclonal antibody. To demonstrate that the polyclonal antibody was monospecific for the targeted phosphorylation site, we performed an analysis of site-directed mutants of ATGL. COS cells were transfected with an ATGL construct or a construct with a substitution of Ser ¡ Ala 406 in ATGL, rendering this site phosphorylation defective. The Western blot in Fig. 1A demonstrates the presence of an immunoreactive band at 54 kDa with the ATGL construct and the absence of this band in the ATGL S406A mutant. Notably, the ATGL Ser 406 polyclonal antibody detected immunoreactive bands in ATGL harbouring S396A and S430A mutations (data not shown). ATGL Ser 406 was also detected in lysates from 3T3-L1 adipocytes, a cell type with high ATGL expression (Fig. 1A) .
ATGL Ser 404 phosphorylation and AMPK signaling during exercise. Total levels of skeletal muscle ATGL were unaffected by exercise (data not shown), and phosphorylation in ATGL Ser 404 was not increased from rest during exercise (Fig.  1B) . Notably, the phosphorylation in ATGL Ser 404 was variable between individuals, with increased phosphorylation between 0 and 60 min apparent in six subjects and decreases in three subjects (Fig. 1C) the exercise-induced change in ATGL Ser 404 phosphorylation (P ϭ 0.10) correlated with the percentage of myosin heavy chain (MHC)1-expressing fibers in muscle (Fig. 1D) . A representative image of the MHC1 staining is shown in Fig. 1E .
AMPK␣1 and -␣2 activities were increased from rest at 5 and 60 min of exercise ( Fig. 2A) . AMPK Thr 172 phosphorylation was not increased during exercise (Fig. 2B) . Conversely, ACC␤ Ser 221 phosphorylation, which is a marker of AMPK activity, was increased 1.3-and 2.7-fold (P Ͻ 0.05) at 5 and 60 min, respectively (Fig. 2C) .
To determine the potential relationship between ATGL Ser 404 phosphorylation and AMPK activity, correlation analysis was performed. ATGL Ser 404 phosphorylation was not associated with AMPK␣1 (Fig. 3A) , AMPK␣2 (Fig. 3B) , or total AMPK activity (r 2 ϭ 0.0003, P ϭ 0.92), and the exerciseinduced change in ATGL Ser 404 phosphorylation from 0 to 60 min was not associated with the change in AMPK activity (0 -60 min, r 2 ϭ 0.02). Consistent with these relationships, ATGL Ser 404 phosphorylation was not associated with AMPK Thr 172 or ACC␤ Ser 221 phosphorylation (data not shown). Furthermore, immunoprecipitation experiments indicates that there was no interaction between ATGL and AMPK in skeletal muscle lysates obtained from humans at rest and at 60 min of exercise (Fig. 3C) . Thus, AMPK does not appear to be a relevant activating kinase in skeletal muscle ATGL Ser 404 . In contrast, ATGL Ser 404 phosphorylation was positively related to the PKA site Ser 563 in HSL (r 2 ϭ 0.23, P ϭ 0.01; Fig. 3D ) and a prominent 90 kDa protein detected by the phospho-(Ser/ Thr) PKA substrate antibody (r 2 ϭ 0.32, P ϭ 0.002; Fig. 3E ). However, ATGL Ser 404 phosphorylation did not significantly correlate with plasma epinephrine at 60 min (r 2 ϭ 0.01, P ϭ 0.76).
Cell culture. To directly determine whether ATGL Ser
406
(corresponding to human Ser 404 ) is responsive to AMPK activation, we incubated C 2 C 12 myoblasts with 500 M and 2 mM AICAR. AICAR increased AMPK Thr 172 sevenfold (P ϭ 0.10) and ACC␤ Ser 221 phosphorylation fourfold compared with nontreated myotubes (Fig. 4, A and B) . ATGL Ser 406 phosphorylation in C 2 C 12 myotubes was unaffected by overnight (16 h) serum removal (data not shown). Consistent with the observations in human skeletal muscle (Fig. 1B) , ATGL Ser 406 phosphorylation was unaffected by AMPK activation (Fig. 4C) . ATGL Ser 406 phosphorylation was also unaffected when myotubes were treated with forskolin, a potent PKA activator (Fig. 4C) .
DISCUSSION
ATGL is a critical regulator of triacylglycerol lipolysis, and the role of phosphorylation in the regulation of ATGL remains understudied. It has been known for some time that ATGL can be phosphorylated in Ser 404 (corresponding to Ser 406 in mice) (6), however, the upstream kinases remained elusive. AMPK directly phosphorylates ATGL in Caenorhabditis elegans to downregulate lipolysis (28) and ensure a slow release of fatty acids during dauer, which is a dormant state characterized by energetic stress. Notably, this AMPK site at the ATGL Ser 303 residue is not phylogenetically conserved. Ahmadian et al. (1) showed that AMPK phosphorylates ATGL in Ser 406 in HEK293 cells and that lipolysis is decreased in murine adipocytes expressing an ATGL S406A mutation, suggesting that AMPK phosphorylates and activates ATGL. Hence, the role of AMPK phosphorylation in ATGL function remains equivocal.
ATGL overexpression in human primary myotubes increases triacylglycerol hydrolysis (5), and significant ATGL activity is present in human skeletal muscle lysates (3). ATGL ablation in mice increases intramyocellular triacylglycerol content, and the oxidation of extracellular derived fatty acids is enhanced in isolated skeletal muscle, indicative of an inability to mobilize intracellular fatty acids stored in triacylglycerol (16) . Hence, ATGL is an important lipase controlling muscle lipid metabolism. In this study, we utilized a phosphospecific polyclonal antibody to determine the phosphorylation state of ATGL, which, based on the data of Ahmadian et al. (1) , provides an indication of the active state of the protein. Our results demonstrate that ATGL Ser 404 phosphorylation is not increased in skeletal muscle of mixed fiber types during moderate-intensity exercise in humans, which is a physiological stress that reproducibly increases triacylglycerol hydrolase activity (31, 43, 45, 46) and triacylglycerol degradation (for review see Ref. 44) . Although previous studies have reported triacylglycerol hydrolase activity in muscle lysates (i.e., the combined activities of ATGL, HSL, and other potential lipases), we were unable to directly measure ATGL activity in skeletal muscle lysates, which first requires immunoprecipitation of ATGL followed by radiometric assessment of activity. in muscle modulates ATGL triacylglycerol hydrolase activity. We have shown, however, that ATGL Ser 404 phosphorylation is related to type I fiber content in muscle, which is consistent with the putative activating role of ATGL Ser 404 (1) and the notion that endurance athletes, who have a high percentage of type I fibers, utilize more intramyocellular triacylglycerol during exercise than untrained individuals (40) .
Although these data suggest that phosphorylation of ATGL Ser 404 is unlikely to be important for direct activation of ATGL triacylglycerol hydrolase activity in mixed skeletal muscle, a role for ATGL Ser 404 in lipolytic regulation cannot be discounted. Instead, phosphorylation in ATGL Ser 404 may facilitate the interaction of ATGL with another protein(s) for increased lipase activity/lipolysis, particularly in type I fibers. By analogy, the major factors controlling adipocyte HSL triacylglycerol hydrolase activity in vivo are increased phosphorylation of perilipin 1 (39) , which permits translocation and interaction of HSL and perilipin 1 to increase lipolysis (33) . Perilipin 1 is not expressed in skeletal muscle, but other proteins expressed in skeletal muscle interact with ATGL to modulate lipolysis (i.e., Plin5, CGI-58) (38) . In this context, the skeletal muscle triacylglycerol pool has a high turnover (15, 32) , and we speculate that the phosphorylation of ATGL Ser 404 in resting muscle may be required to maintain triacylglycerol turnover. Thus, phosphorylation of ATGL Ser 404 may be important for sustaining spontaneous (basal) muscle lipolysis, but not "stimulated" lipolysis. An alternative possibility is that phosphorylation of ATGL Ser 404 may be important in mediating acylglycerol transacylase activity of ATGL (18) rather than triacylglycerol hydrolysis and thus facilitate fatty acid cycling.
The data presented herein indicate that the "energy sensor" AMPK does not phosphorylate ATGL Ser 404 in skeletal muscle in vivo. While the amino acid sequence surrounding ATGL Ser 404 (LRRAQSLP) predicts phosphorylation by AMPK, AMPK activity/signaling did not correlate with ATGL Ser 404 phosphorylation in human skeletal muscle at rest and during exercise. In addition, there was no evidence of a physical interaction between ATGL and AMPK after immunoprecipitation, and pharmacological activation of AMPK did not affect ATGL Ser 404 phosphorylation in cultured myotubes. Thus, in contrast to previous results (1), we show that AMPK does not phosphorylate skeletal muscle ATGL Ser 404 in intact cell systems or whole organisms. It is possible that the AMPK activation induced by exercise in humans was insufficient to mediate an increase in AMPK Ser 404 phosphorylation, although this is unlikely for the cell culture experiments because the AICAR concentrations were similar between this and a previous study demonstrating phosphorylation of ATGL (1) . Alternatively, the phosphoregulation of ATGL may be subject to tissue-specific regulation, hence explaining the apparent differences seen in skeletal muscle and adipocytes (1) . Phosphoproteomic screens in several tissues from the same animal suggested that the "typical" phosphoprotein is widely expressed yet displays variable, often tissue-specific phosphorylation (17) . This is proposed to tune the activity of proteins to the specific needs of each tissue within the organism. While not completely discounting the possibility of tissue-specific regulation here, such differential regulation in adipocytes compared with skeletal muscle is unlikely given the magnitude of AMPK activation in skeletal muscle vs. adipose tissue during exercise (23) .
PKA activation is central to lipolytic activation in skeletal muscle (19, 25, 47) , and we hypothesized that PKA phosphorylates ATGL. Although our studies in exercising humans showed a positive correlation between ATGL Ser 404 phosphorylation and PKA signaling, direct studies in C 2 C 12 myotubes showed no effect of forskolin on ATGL Ser 406 phosphorylation. Together, these studies suggest that neither AMPK nor PKA appears to be an important upstream kinase of ATGL in skeletal muscle.
In summary, this study demonstrates that phosphorylation of ATGL Ser 404 is not increased during moderate-intensity exercise in human skeletal muscle, questioning the importance of this site for stimulated lipolysis in skeletal muscle. Our data also question the importance of AMPK in regulating ATGL and muscle lipolysis in vivo. Thus, these studies do not support an activating role for AMPK in muscle lipolysis and further highlight the differences in the regulation of adipocyte and muscle lipolysis.
